Vanda Pharmaceuticals | Actif À Court Terme





Actif À Court Terme Changement Date
Acadia Pharmaceuticals USD 1.08B 115.87M 2025-09
Agios Pharmaceuticals USD 1.03B 13.64M 2025-09
Akebia Therapeutics USD 258.34M 23.68M 2025-09
Alnylam Pharmaceuticals USD 3.95B 309.11M 2025-09
Anika Therapeutics USD 101.59M 2.27M 2025-09
Arrowhead Research USD 1.17B 223.75M 2025-12
AstraZeneca USD 28.72B 1.22B 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Eli Lilly USD 62.07B 12.22B 2025-09
Enanta Pharmaceuticals USD 204.34M 18.37M 2025-09
Esperion Therapeutics USD 360.46M 17.87M 2025-09
Halozyme Therapeutics USD 1.33B 206.08M 2025-09
Heron Therapeutics USD 229.4M 18.48M 2025-09
Insmed USD 1.93B 149.77M 2025-09
J&J USD 54.61B 113M 2025-09
Lexicon Pharmaceuticals USD 145.08M 100.72M 2025-06
Ligand Pharmaceuticals USD 753.92M 400.98M 2025-09
Merck USD 47.56B 10.49B 2025-09
Minerva Neurosciences USD 13.02M 2.53M 2025-09
Moderna USD 6.6B 427M 2025-09
Novartis USD 28.2B 2.26B 2025-09
Pfizer USD 46.92B 3.22B 2025-09
PTC Therapeutics USD 2.01B 265.07M 2025-09
Puma Biotechnology USD 143.58M 7M 2025-09
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sanofi EUR 30.95B 3.09B 2025-12
Takeda JPY 3.12T 195.82B 2025-12
Teva Pharmaceutical Industries USD 13.95B 1.21B 2025-12
Ultragenyx Pharmaceutical USD 643.21M 76.58M 2025-09
Vanda Pharmaceuticals USD 367.5M 27.42M 2025-09
Veracyte USD 449.22M 34.54M 2025-09


Vanda Pharmaceuticals Actif À Court Terme - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.